The PD-1/PD-L1 Pathway in Human Pathology

By  

Current Molecular Medicine, Vol. 12, Iss. 3, 2012-03 ,pp. : 259-267

Bentham Science Publishers

Access to resources Recommend Favorite

Specific and high-affinity binding of tetramerized PD-L1 extracellular domain to PD-1-expressing cells: possible application to enhance T cell function

By Terawaki Seigo   Tanaka Yoshimasa   Nagakura Tomokazu   Hayashi Tamon   Shibayama Shiro   Muroi Kaori   Okazaki Taku   Mikami Bunzo   Garboczi David N.   Honjo Tasuku   Minato Nagahiro  

International Immunology, Vol. 19, Iss. 7, 2007-07 ,pp. : 881-890

Oxford University Press

Access to resources Recommend Favorite

PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1

By Ghiotto Marguerite   Gauthier Laurent   Serriari Nacer   Pastor Sonia   Truneh Alemseged   Nuns Jacques A.   Olive Daniel  

International Immunology, Vol. 22, Iss. 8, 2010-05 ,pp. : 651-660

Oxford University Press

Access to resources Recommend Favorite

Immunological studies on PD-1-deficient mice: implication of PD-1 as a negative regulator for B cell responses

By Minato N.  

International Immunology, Vol. 10, Iss. 10, 1998-10 ,pp. : 1563-1572

Oxford University Press

Access to resources Recommend Favorite

PD-1PD-L1 pathway impairs T h 1 immune response in the late stage of infection with Mycobacterium bovis bacillus CalmetteGurin

By Sakai Shunsuke   Kawamura Ikuo   Okazaki Taku   Tsuchiya Kohsuke   Uchiyama Ryousuke   Mitsuyama Masao  

International Immunology, Vol. 22, Iss. 12, 2010-12 ,pp. : 915-925

Oxford University Press

Access to resources Recommend Favorite